Safety and Efficacy of Cariprazine for Bipolar I Disorder
Public ClinicalTrials.gov record NCT01058668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Study identification
- NCT ID
- NCT01058668
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 497 participants
Conditions and interventions
Conditions
Interventions
- Cariprazine Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Apr 11, 2017
2010 – 2011
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 018 | Little Rock | Arkansas | 72211 | — |
| Forest Investigative Site 012 | Cerritos | California | 90703 | — |
| Forest Investigative Site 010 | Costa Mesa | California | 92626 | — |
| Forest Investigative Site 005 | Oceanside | California | 92056 | — |
| Forest Investigative Site 023 | San Diego | California | 92102 | — |
| Forest Investigative Site 017 | San Diego | California | 92103 | — |
| Forest Investigative Site 024 | Santa Ana | California | 92701 | — |
| Forest Investigative Site 016 | New Britain | Connecticut | 06050 | — |
| Forest Investigative Site 007 | Washington D.C. | District of Columbia | 20016 | — |
| Forest Investigative Site 002 | Kissimmee | Florida | 34741 | — |
| Forest Investigative Site 003 | Orlando | Florida | 32821 | — |
| Forest Investigative Site 026 | Atlanta | Georgia | 30308 | — |
| Forest Investigative Site 013 | Honolulu | Hawaii | 96813 | — |
| Forest Investigative Site 011 | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site 021 | Greenwood | Indiana | 46143 | — |
| Forest Investigative Site 001 | Shreveport | Louisiana | 71115 | — |
| Forest Investigative Site 006 | Rockville | Maryland | 20850 | — |
| Forest Investigative Site 025 | St Louis | Missouri | 63118 | — |
| Forest Investigative Site 008 | Cedarhurst | New York | 11516 | — |
| Forest Investigative Site 019 | Philadelphia | Pennsylvania | 19139 | — |
| Forest Investigative Site 015 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 004 | Irving | Texas | 75062 | — |
| Forest Investigative Site 014 | Bothell | Washington | 98011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01058668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 11, 2017 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01058668 live on ClinicalTrials.gov.